Skin Lite Cream – 25 g

Skin Lite Cream is a prescription-strength triple-active topical cream formulated for the short-term management of moderate to severe melasma on the face. It combines a depigmenting agent, a retinoid, and a corticosteroid to help improve the appearance of dark facial patches when used under medical supervision and alongside strict sun protection.

This formulation is intended for short-term use only and is not suitable for long-term or maintenance therapy.

Active Ingredients & Their Role

• Hydroquinone 2% – A melanin synthesis inhibitor that targets tyrosinase, the key enzyme in melanin biosynthesis, helping reduce excess pigmentation associated with melasma (Vashi NA & Kundu RV, Br J Dermatol, 2013;169 Suppl 3:41-56).
• Tretinoin 0.025% – A vitamin A derivative (retinoid) that accelerates keratinocyte turnover, disperses epidermal melanin, and enhances hydroquinone penetration for improved depigmentation (Rendon et al., J Am Acad Dermatol, May 2006).
• Mometasone Furoate 0.1% – A potent topical corticosteroid that reduces inflammation, minimises retinoid-induced irritation, and provides additive depigmentation through suppression of cellular metabolic activity.

The exact mechanism of action of the combination in melasma is not fully known.

Clinical Evidence & Benefits

Triple-combination topical therapies combining a depigmenting agent, retinoid, and corticosteroid represent the gold standard first-line treatment for melasma according to current dermatological consensus:

• Hydroquinone-based triple combinations have demonstrated superior efficacy over dual-agent or monotherapy regimens in randomised controlled trials (Taylor SC et al., Cutis, 2003;72(1):67-72)
• Tretinoin promotes epidermal cell renewal and pigment elimination while preventing hydroquinone oxidation, maintaining therapeutic activity (Grimes P & Watson J, Cutis, 2013;91(1):47-54)
• The corticosteroid component provides anti-inflammatory synergy, reducing treatment-associated erythema and irritation, improving adherence
• Clinical studies confirm triple-combination formulations achieve meaningful pigment reduction within 4–8 weeks of once-daily nocturnal application
• Sun avoidance remains critical — even minimal UV exposure can trigger melanocyte activity and reverse treatment gains

Indication

Skin Lite Cream is used for the short-term treatment of moderate to severe melasma of the face, in combination with sun-avoidance measures including broad-spectrum sunscreen (SPF 30 or higher), protective clothing, and avoidance of direct sunlight and UV exposure. It is not indicated for long-term use or maintenance therapy.

Key Features

• Triple-active combination cream targeting the three pathways of melasma
• Designed for facial use only
• Prescription-strength formulation
• Intended for short-term use under medical guidance
• 25 g tube suitable for a controlled treatment course

How to Use

• Apply a thin layer once daily at night to affected areas of the face
• Use only as directed by a healthcare professional
• Wash hands thoroughly after application
• Avoid contact with eyes, lips, nostrils, and broken skin
• Use SPF 30+ broad-spectrum sunscreen every morning during treatment

Sun Protection Advice

Sun exposure can worsen melasma and reduce treatment effectiveness. While using Skin Lite Cream:

• Avoid sunlight and UV exposure
• Use SPF 30+ sunscreen daily
• Wear protective clothing and hats
• Do not use tanning beds or sunlamps

Possible Side Effects

Some users may experience redness, burning, peeling, dryness, itching, acne, or increased skin sensitivity. Prolonged or inappropriate use may increase the risk of skin thinning, steroid-related effects, or rebound pigmentation. If severe irritation, unusual skin changes, or discomfort occurs, discontinue use and consult a doctor immediately.

Who Should NOT Use This Product

• Pregnant or breastfeeding women
• Individuals allergic to any listed ingredient
• Children, unless specifically advised by a doctor
• Patients requiring long-term or maintenance treatment of melasma

Always consult a healthcare professional before use.

Important Notes

• Skin Lite Cream improves appearance but is not a cure for melasma
• Melasma may recur after discontinuation of treatment
• Long-term or unsupervised use is not recommended

Product Details

• Product Name: Skin Lite Cream
• Active Ingredients: Hydroquinone 2% / Tretinoin 0.025% / Mometasone Furoate 0.1%
• Net Weight: 25 g
• Form: Topical cream
• Application Area: Face only
• Classification: Prescription-strength / doctor-advised use

 Always consult your doctor or dermatologist before use. Individual results may vary.